Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Am J Clin Oncol. 2010 Dec;33(6):533-43. doi: 10.1097/COC.0b013e3181b9cf1b.

Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort.

Author information

  • 1University of Texas Health Science Center, Houston, USA. xianglin.l.du@uth.tmc.edu

Abstract

BACKGROUND:

Several small scale clinical trials indicated a possible relationship between chemotherapy administration and the increased risk of cognitive impairments in patients with breast cancer, but little information was available from large population-based cohort studies.

METHODS:

We studied 62,565 women who were diagnosed with stages I-IV breast cancer at age ≥65 years from 1991 through 2002 from 16 regions in the Surveillance, Epidemiology and End Results program who were free of cognitive impairments at diagnosis with up to 16 years of follow-up, and also studied 9752 matched cohort based on the propensity of receiving chemotherapy. The cumulative incidence of cognitive impairments was calculated and the time to event (cognitive impairments) analysis was conducted using Cox hazard regression model.

RESULTS:

Overall, patients who received chemotherapy were 8% more likely to have drug-induced dementia compared with those without chemotherapy, but that was not statistically significant after adjusting for patient and tumor characteristics (hazard ratio = 1.08, 95% confidence interval = 0.85-1.37). The risk of developing Alzheimer disease, vascular dementia, or other dementias was significantly lower in patients receiving chemotherapy except for cognitive disorder which was not significantly different between the 2 chemotherapy groups. The results were somewhat similar in the entire cohort and the matched cohort based on the probability of receiving chemotherapy.

CONCLUSION:

There was no significant association between chemotherapy and the risk of developing drug-induced dementia and unspecified cognitive disorders. The risk of developing Alzheimer disease, vascular dementia, or other dementias was significantly lower in patients receiving chemotherapy. This study with long-term follow-up did not support the findings that chemotherapy was associated with an increased risk of late stage cognitive impairments.

PMID:
20023570
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk